Reply to: “The age of procalcitonin: Potential pitfalls in critically ill patients with SJS/TEN. A comment on ‘Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients’”
2020 ◽
Vol 82
(6)
◽
pp. e249
2020 ◽
Vol 82
(6)
◽
pp. e247
◽
Keyword(s):
2019 ◽
Vol 81
(3)
◽
pp. 686-693
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 20
(5)
◽
pp. 741-741
2019 ◽
Vol 20
(4)
◽
pp. 579-592
◽
Keyword(s):
2019 ◽
Vol 58
(10)
◽
pp. 1141-1147
◽